====== National Advisory Committee on Immunization ======

{{ ::screen_shot_2022-03-19_at_1.13.01_am.png?200|}}

The **National Advisory Committee on Immunization** (NACI) is a Canadian advisory body operating within the [[Public Health Agency of Canada]] (PHAC).((Public Health Agency of Canada. (2022, September 16). //National Advisory Committee on Immunization (NACI): Terms of reference.// Government of Canada. https://web.archive.org/web/20230406185629/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/terms-references.html)) It is tasked with "providing guidance on the use of [[vaccines]] currently or newly approved for use in Canada to the [[Government of Canada]]."((Public Health Agency of Canada. (2022, April 22). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))

===== History =====

NACI was formed in 1964.((Public Health Agency of Canada. (2022, April 22). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))

==== COVID-19 ====

On April 23, 2021, NACI recommended the [[covid-19_vaccines:Vaxzevria|AstraZeneca-Oxford COVID-19 vaccine]] be offered to "all Canadians over the age of 30, but only when the benefits outweigh the risks of rare, serious post-vaccine blood clots."((Pelley, L. (2021, April 23). //Canadians over 30 should be offered AstraZeneca-Oxford COVID-19 vaccine, advisory body recommends.// CBC News. http://archive.today/2021.04.24-073245/https://www.cbc.ca/news/health/astrazeneca-covid-19-vaccine-over-30-naci-1.6000052))

On June 29, 2022, NACI issued guidance recommending "booster doses" of [[:COVID-19 vaccines]] for all "Canadians at increased risk of serious illness from [[COVID-19]]", regardless of how many doses they had previously received.((Boynton, S. (2022, June 19). //COVID-19 boosters recommended this fall ahead of future pandemic wave: NACI.// Global News. http://archive.today/2023.04.19-201142/https://globalnews.ca/news/8957899/naci-covid-19-boosters-fall-canada/))

On March 3, 2023, NACI called for "high-risk individuals" to receive another booster dose in the spring.((National Advisory Committee on Immunization. (2023, March 3). //Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19.// Public Health Agency of Canada. https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-additional-covid-19-booster-dose-spring-2023-individuals-high-risk-severe-illness-due-covid-19/statement.pdf)) ((Pelley, L. (2023, March 3). //COVID-19 booster shots recommended for high-risk Canadians starting this spring.// CBC News. https://web.archive.org/web/20230419211957/https://www.cbc.ca/news/health/covid-booster-recommendations-1.6767057))

===== Organization =====

==== Members ====

^  Current Members((Public Health Agency of Canada. (2022, April 22). //National Advisory Committee on Immunization (NACI): Membership and representation.// Government of Canada. https://archive.ph/CDZrB))  ^^^
^ Name  ^ Position  ^ Notes  ^
| [[Shelley Deeks]]  | Chair  | Member of committees under [[World Health Organization]] and [[GAVI]], and funded by the [[Bill & Melinda Gates Foundation]].  |
| [[Robyn Harrison]]  | Vice-chair  | [[University of Alberta]]  |
| [[Melissa Andrew]]  | Member  | -  |
| [[Julie Bettinger]]  | Member  | -  |
| [[Nicholas Brousseau]]  | Member  | -  |
| [[Hélène Decaluwe]]  | Member  | -  |
| [[Philippe De Wals]]  | Member  | -  |
| [[Eve Dubé]]  | Member  | -  |
| [[Vinita Dubey]]  | Member  | -  |
| [[Kyla Hildebrand]]  | Member  | -  |
| [[Kristin Klein]]  | Member  | -  |
| [[Jesse Papenburg]]  | Member  | -  |
| [[Anne Pham-Huy]]  | Member  | -  |
| [[Beate Sander]]  | Member  | -  | 
| [[Susan Smith]]  | Member  | -  |
| [[Sarah Wilson]]  | Member  | -  |
| [[Matthew Tunis]]  | Executive Secretary  | -  |
| -  | Liaison Representative for the [[Association of Medical Microbiology and Infectious Disease Canada]]  | -  |
| [[Deshayne Fell]]  | Liaison Representative for the [[Canadian Association for Immunization Research and Evaluation]]  | -  |
| [[Monika Naus]]  | Liaison Representative for the [[Canadian Immunization Committee]]  | -  |
| [[Lea Bill]]  | Liaison Representative for the [[Canadian Indigenous Nurses Association]]  | -  |
| [[Lucie Marisa Bucci]]  | Liaison Representative for the [[Canadian Public Health Association]]  | -  |
| [[Dorothy Moore]]  | Liaison Representative for the [[Canadian Paediatric Society]]  | -  |
| [[Amanda Ung]]  | Liaison Representative for the [[Canadian Pharmacists Association]]  | -  |
| [[Amanda Cohn]]  | Liaison Representative for the [[Center for Disease Control and Prevention|U.S. Centers for Disease Control and Prevention]]  | -  |
| [[Martin Lavoie]]  | Liaison Representative for the [[Council of Chief Medical Officers of Health]]  | -  |
| [[Sarah Funnell]]  | Liaison Representative for the [[Indigenous Physicians Association of Canada]]  | -  |
| [[Eliana Castillo]]  | Liaison Representative for the [[Society of Obstetrics and Gyneacologists]]  | -  |
| [[Lorette Dupuis]]  | Liaison Representative for the [[Canadian Nurses Association]]  | -  |
| [[Jia Hu]]  | Liaison Representative for the [[College of Family Physicians of Canada]]  | -  |
| [[Celia Lourenco]]  | Ex-officio Representative for the [[Biologics and Genetic Therapies Directorate]], [[Health Canada]]  | -  |
| [[Erin Henry]]  | Ex-officio Representative for the [[Centre for Immunization Readiness]], [[Public Health Agency of Canada]]  | -  |
| [[Susanna Ogunnaike-Cooke]]  | Ex-officio Representative for Vaccine Safety, [[Public Health Agency of Canada]]  | -  |
| [[Diane MacDonald]]  | COVID-19 Epidemiology and Surveillance, [[Public Health Agency of Canada]]  | -  |
| [[Vincent Beswick-Escanlar]]  | [[Directorate of Force Health Protection, National Defense]] and the [[Canadian Armed Forces]]  | -  |
| [[Guillaume Poliquin]]  | [[National Microbiology Laboratory]], [[Public Health Agency of Canada]]  |
| [[Tom Wong]]  | [[First Nations and Inuit Health Branch]], [[Indigenous Services Canada]]  | -  |
| [[Kelly Robinson]]  | [[Marketed Health Products Directorate]], [[Health Canada]]  | -  |
| [[Mireille Lacroix]]  | [[Public Health Ethics Consultative Group]]  | -  |
| [[Nicole Forbes]]  | Secretariat((//Where Are They Now: Nicole Forbes.// (2020, November 20). BioCanRx. https://web.archive.org/web/20230316080334/https://biocanrx.com/now-nicole-forbes))  | -  |
^  Former  ^^^
^ Name  ^ Position  ^ Notes  ^
| [[Natalie Dayneka]]  | Member  | -  |
| [[Soren Gantt]]  | Member  | Funding from [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Moderna]], [[pharmaceutical_companies:Pfizer]] |
| [[Coleman Rotstein]]  | Member  | Funding from [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:Avir Pharma]], [[pharmaceutical_companies:Chimerix]], [[pharmaceutical_companies:Cidara Therapeutics]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Pendopharm]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Sunovion]], and [[pharmaceutical_companies:Teva]]  |
| [[Althea House]]  | Manager  | -  |
| [[Deborah Danoff]]  | Ex-officio representative for the [[Marketed Health Products Directorate]]  | -  |
| [[Julie Emili]]  | Liaison representative for the [[College of Family Physicians of Canada]]  | -  |
| [[Jennifer Pennock]]  | Ex-officio representative for the Surveillance and Epidemiology Division of the [[Centre for Immunization and Respiratory Infectious Diseases]] (CIRID) at [[Public Health Agency of Canada]]  | -  |
| [[Robert Pless]]  | Ex-officio representative for the [[Biologics and Genetic Therapies Directorate]] at [[Health Canada]]  | -  |